AI Generated Image
Agitation in Dementia Can Be Helped by Medical Cannabis, Study Suggests
The New York Times • • health
Key Points:
- A clinical trial involving 120 patients with advanced dementia found that a treatment combining THC and CBD significantly reduced agitation in nearly 90% of participants after 12 weeks, compared to less than 25% in the placebo group.
- Dennys Gonzalez, whose 87-year-old father participated in the trial, reported a marked decrease in his father's aggression and distress during the treatment.
- Medical experts suggest that cannabinoid treatments could be a promising option to address agitation in advanced dementia, though the study's results have not yet been peer-reviewed or published.
- Elizabeth Edgerly of the Alzheimer’s Association emphasized the potential of this treatment to alleviate suffering but noted that larger trials are needed to confirm the findings.
